Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic population pharmacokinetics of albumin-bound paclitaxel in solid tumors
ChiCTR2300067853Phase 4Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paclitaxel in Nonhematologic neoplasms, sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: Albumin-bound paclitaxel plasma concentration and Tumor size. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
paclitaxel
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on ChiCTR2300067853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067853.